Pipeline API

Showing 17–23 of 23 results

Osimertinib API
₹6,952,694,785.00 Add to cart
Relugolix
₹6,952,694,785.00 Add to cart
Resmetirom
₹6,952,694,785.00 Add to cart
Ribociclib succinate
₹6,952,694,785.00 Add to cart
Tafamidis
₹6,952,694,785.00 Add to cart
Treosulfan
₹6,952,694,785.00 Add to cart
Upadacitinib API
₹6,952,694,785.00 Add to cart

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.

Social Networks

Useful Links

Specialized Offerings

HPAPI

API

ADC Linkers

Polyethylene Glycol (PEGs)

Corporate Office Address:

Manufacturing Site Address:

Offering CDMO Services from Discovery to Commercialization

With a strong international footprint, Shilpa Pharma serves partners across key markets worldwide:

India
United States
Canada
China
Germany
France
Japan
Central America States
Brazil
Australia
Singapore
Taiwan
UAE
Saudi Arabia
South Korea
Russia
Egypt
South Africa
United Kingdom & Continental Europe
ROW Markets

Osimertinib API

Relugolix

Resmetirom

Ribociclib succinate

Tafamidis

Treosulfan

Upadacitinib API